BAY 2927088, an oral, reversible tyrosine kinase inhibitor (TKI) that potently inhibits mutant HER2, led to promising response rates when used for the treatment of patients with pretreated HER2 ...

Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female ...

Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...

New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

Researchers found that pesticide exposure may contribute to 154.1% more non-Hodgkin lymphoma cases than smoking.

Researchers explore the global rise in early-onset cancers, linking environmental exposures and lifestyle changes to the ...

Researchers develop synthetic antibody that, when combined with common lung cancer drug, prevents relapse of adenocarcinoma ...

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is ...

Exposure to air pollution in the form of soot particles smaller than 2.5 micrometers (PM2.5) has been linked to a lung cancer ...

Lung cancer is tied to tobacco smoking in the public consciousness, but a significant proportion of cases are driven by ...

In a significant advancement in cancer treatment, doctors have initiated trials for the world’s first mRNA lung cancer vaccine. This vaccine is being developed by the same German company behind the ...

Detailed results from one of AstraZeneca's key lung cancer trials released on Monday showed that its experimental precision ...